Head-to-Head drug battle for a hidden hormone disorder
NCT ID NCT07268222
Summary
This study is comparing two existing drugs, metyrapone and osilodrostat, to see which one works better for adults with a condition where their adrenal glands produce too much cortisol. The goal is to control the hormone levels and improve related health problems like high blood pressure, weight gain, and blood sugar issues. Researchers will measure hormone levels, body weight, blood pressure, and metabolic markers over 6 months of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD AUTONOMOUS CORTISOL SECRETION (MACS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Laikon General Hospital
RECRUITINGAthens, Greece
Conditions
Explore the condition pages connected to this study.